LifeStance Health Group, Inc.
LFST
$8.10
$0.172.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.49B | 1.42B | 1.37B | 1.32B | 1.28B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.49B | 1.42B | 1.37B | 1.32B | 1.28B |
| Cost of Revenue | 1.01B | 963.19M | 923.33M | 888.39M | 866.04M |
| Gross Profit | 487.24M | 461.10M | 444.24M | 428.09M | 417.46M |
| SG&A Expenses | 388.05M | 382.24M | 380.55M | 369.77M | 367.14M |
| Depreciation & Amortization | 54.32M | 54.75M | 55.99M | 57.55M | 62.14M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.45B | 1.40B | 1.36B | 1.32B | 1.30B |
| Operating Income | 44.87M | 24.11M | 7.70M | 769.00K | -11.82M |
| Income Before Tax | 33.59M | 12.36M | -11.72M | -21.67M | -38.35M |
| Income Tax Expenses | 10.40M | 2.70M | -2.60M | -5.52M | -2.71M |
| Earnings from Continuing Operations | 23.20 | 9.66 | -9.12 | -16.15 | -35.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.20M | 9.66M | -9.12M | -16.15M | -35.64M |
| EBIT | 44.87M | 24.11M | 7.70M | 769.00K | -11.82M |
| EBITDA | 99.19M | 78.86M | 63.69M | 58.32M | 50.32M |
| EPS Basic | 0.06 | 0.02 | -0.02 | -0.04 | -0.09 |
| Normalized Basic EPS | 0.06 | 0.02 | -0.02 | -0.03 | -0.06 |
| EPS Diluted | 0.06 | 0.02 | -0.03 | -0.05 | -0.10 |
| Normalized Diluted EPS | 0.05 | 0.02 | -0.02 | -0.03 | -0.06 |
| Average Basic Shares Outstanding | 1.55B | 1.54B | 1.54B | 1.53B | 1.52B |
| Average Diluted Shares Outstanding | 1.57B | 1.56B | 1.55B | 1.54B | 1.53B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |